Sunnyvale, CA, United States of America

Sharathchandra Surendra Hegde

This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharathchandra Surendra Hegde. Retrieved from https://idiyas.com/inventor/sharathchandra-surendra-hegde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sharathchandra Surendra Hegde

Introduction

Sharathchandra Surendra Hegde is an accomplished inventor based in Sunnyvale, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of muscarinic receptor antagonist compounds. His work has implications for various therapeutic applications.

Latest Patents

Hegde holds a patent for 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives. This invention relates to a specific group of compounds represented by Formula I, which are designed to act as muscarinic receptor antagonists. His innovative approach in this area has the potential to advance treatment options in pharmacology.

Career Highlights

Sharathchandra Hegde is currently employed at Syntex (U.S.A.) Inc., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has led to the successful development of new compounds that may enhance therapeutic efficacy.

Collaborations

Hegde has collaborated with notable colleagues, including Michael Patrick Dillon and Joan Marie Caroon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.

Conclusion

Sharathchandra Surendra Hegde's contributions to medicinal chemistry and his innovative patent work exemplify the impact of dedicated inventors in advancing healthcare solutions. His ongoing research at Syntex (U.S.A.) Inc. continues to pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…